Response to Letter to the Editor: 'Use of preoperative comorbidity scores to predict mortality after total arthroplasty'.
Quality Use of Medicines and Pharmacy Research Centre, Medicine and Device Surveillance Centre of Research Excellence, Sansom Institute, School of Pharmacy and Medical Sciences, University of South Australia, GPO Box 2471, Adelaide 5001, South Australia, Australia. Electronic address: maria.inacio@unisa.edu.au.
M C S
MC
Inacio
Quality Use of Medicines and Pharmacy Research Centre, Medicine and Device Surveillance Centre of Research Excellence, Sansom Institute, School of Pharmacy and Medical Sciences, University of South Australia, GPO Box 2471, Adelaide 5001, South Australia, Australia.
N L
NL
Pratt
Quality Use of Medicines and Pharmacy Research Centre, Medicine and Device Surveillance Centre of Research Excellence, Sansom Institute, School of Pharmacy and Medical Sciences, University of South Australia, GPO Box 2471, Adelaide 5001, South Australia, Australia.
E E
EE
Roughead
Australian Orthopaedic Association, National Total Joint Replacement Registry, Level 6, Bice Building, Royal Adelaide Hospital, The University of Adelaide, Adelaide 5005, South Australia, Australia.
S E
SE
Graves
D019644:Arthroplasty, Replacement, Hip; D019645:Arthroplasty, Replacement, Knee; D015897:Comorbidity; D006801:Humans